Terms: = Cervical cancer AND DNMT3A, Q9Y6K1, 1788, ENSG00000119772, DNMT3A2, M_HsaIIIA AND Treatment
6 results:
1. Overexpression of MicroRNA 142-5p Suppresses the Progression of cervical cancer through Targeting Phosphoinositol-3-Kinase Adaptor Protein 1 Expression.
Guo J; Tang T; Li J; Yang Y; Quan Y; Zhang L; Huang W; Zhou M
Mol Cell Biol; 2021 May; 41(6):e0036320. PubMed ID: 33288643
[TBL] [Abstract] [Full Text] [Related]
2. Concurrent chemoradiotherapy vs. radiotherapy alone in locally advanced cervix cancer: A systematic review and meta-analysis.
Datta NR; Stutz E; Liu M; Rogers S; Klingbiel D; Siebenhüner A; Singh S; Bodis S
Gynecol Oncol; 2017 May; 145(2):374-385. PubMed ID: 28188016
[TBL] [Abstract] [Full Text] [Related]
3. Effect of patient navigation on satisfaction with cancer-related care.
Wells KJ; Winters PC; Jean-Pierre P; Warren-Mears V; Post D; Van Duyn MA; Fiscella K; Darnell J; Freund KM;
Support Care Cancer; 2016 Apr; 24(4):1729-53. PubMed ID: 26438146
[TBL] [Abstract] [Full Text] [Related]
4. HPV16 activates the promoter of Oct4 gene by sequestering HDAC1 from repressor complex to target it to proteasomal degradation.
Liu D; Zhou P; Zhang L; Zheng Y; He F
Med Hypotheses; 2012 Oct; 79(4):531-4. PubMed ID: 22867868
[TBL] [Abstract] [Full Text] [Related]
5. HDAC1/dnmt3a-containing complex is associated with suppression of Oct4 in cervical cancer cells.
Liu D; Zhou P; Zhang L; Gong W; Huang G; Zheng Y; He F
Biochemistry (Mosc); 2012 Aug; 77(8):934-40. PubMed ID: 22860916
[TBL] [Abstract] [Full Text] [Related]
6. Differential expression of Oct4 in HPV-positive and HPV-negative cervical cancer cells is not regulated by DNA methyltransferase 3A.
Liu D; Zhou P; Zhang L; Wu G; Zheng Y; He F
Tumour Biol; 2011 Oct; 32(5):941-50. PubMed ID: 21674242
[TBL] [Abstract] [Full Text] [Related]
